Pfizer to request coronavirus vaccine emergency use authorization ‘within days’

Pfizer announced in a tweet on Wednesday that its coronavirus vaccine candidate met all primary efficacy endpoints in a phase 3 clinical trial, and that it planned to file for emergency use authorization “within days.”